Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-27T22:15:23.010Z Has data issue: false hasContentIssue false
  • English
  • Français

Antidepressant Advertising in China and the UK: The Strengths and Limits of Policy Learning

Published online by Cambridge University Press:  12 March 2019

Robert Geyer  and
Fang Wang
Robert Geyer
Affiliation:
Department of Politics, Philosophy and Religion, Lancaster University. Email: r.geyer@lancaster.ac.uk.
Fang Wang*
Affiliation:
Centre for Translation Studies, University of Surrey
*
Email: fang.wang@surrey.ac.uk (corresponding author).
Get access Rights & Permissions [Opens in a new window]

Abstract

China is expected to become one of the largest markets for prescription drugs in the world and pharmaceutical advertising is becoming increasingly important, particularly in the socially and culturally contested area of mental health. This article briefly explores the background of drug advertising policies in China and the UK and focuses on the distinctive challenges of antidepressant drug regulation. Then, using tools of critical discourse analysis, it examines Chinese antidepressant adverts, and compares them with relevant British adverts. The findings indicate that, relative to the UK, Chinese antidepressant adverts are generally oversimplified, and the critical information concerning the concepts of caution, danger and adverse effects are underrepresented. However, there are many interdependent factors that contribute to the distinctive Chinese antidepressant drug regulatory regime. Hence, Chinese policymakers must maintain a delicate balance between learning from Western regulatory regimes, but also avoiding borrowing too heavily from them.

摘要

随着中国正在逐渐成为世界上最大的处方药物市场，药物广告，尤其是精神类药物广告由于其复杂的社会与文化属性而经常成为一个充满争议的热点话题。本文首先阐述了中英两国广告政策的异同，并着重分析了在抗抑郁症药物广告领域中国目前面临的挑战。然后，运用批评话语分析的研究方法，本研究详细比较了中英两国抗抑郁症药物广告的话语特点，并发现相比较于英国而言，中国目前的抗抑郁症药物广告存在整体文本过于简单化，对药物的不良反应，风险性及注意事项等方面表述不足的问题。这一现象和中国特有的抗抑郁症药物管理体系及其他因素息息相关。因此相关领域政策制定者需要在借鉴他国经验和保持本国管理体系特色两者之间寻求一种合理的平衡状态。

Keywords

antidepressant advertisingChinacritical discourse analysis (CDA)prescription drug regulationpolicy learning抗抑郁症药物广告中国批评话语分析处方药广告规则政策相互学习
Type
Research Article
Information
The China Quarterly , Volume 239 , September 2019 , pp. 752 - 774
Copyright
Copyright © SOAS University of London 2019 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

ABPI (Association of British Pharmaceutical Industry). 2016. Code of Practice for the Pharmaceutical Industry 2016, https://www.abpi.org.uk/media/1605/code_of_practice_2016.pdf. Accessed 19 July 2018.Google Scholar
Ansell, Chris, and Geyer, Robert. 2017. “Pragmatic complexity: a new foundation for moving beyond evidence based policy making.” Policy Studies 38(2), 149–167.Google Scholar
Bai, Yuping. 2015. “Case studies of the approval of food and drug advertisements,” Baidu Wenku, July, 2015, http://wenku.baidu.com/view/4e579888650e52ea551898a8.html. Accessed 20 July 2016.Google Scholar
Baum, E.L. 2013. Spit, Chains, and Hospital Beds: A History of Madness in Republican Beijing, 1912–1938. San Diego: University of California.Google Scholar
Benson, David, and Jordan, Andrew. 2011. “What have we learned from policy transfer research: Dolowitz and Marsh revisited.” Political Studies Review 9(3), 366–378.Google Scholar
Byrne, David, and Callaghan, Gillian. 2013. Complexity Theory and the Social Sciences: The State of the Art. Abingdon: Routledge.Google Scholar
Cairney, Paul. 2015. The Politics of Evidence-Based Policy Making. London: Palgrave.Google Scholar
Cameron, Lynne, and Larsen-Freeman, Diane. 2007. “Complex systems and applied linguistics.” International Journal of Applied Linguistics 17(2), 226–240.Google Scholar
Cohen, David., McCubbin, Michael, Collin, Johanne and Pérodeau, Guilhème. 2001. “Medications as Social Phenomena.” Health 5(4), 441–469.Google Scholar
Council of the European Union. 1992. Council Directive 92/28/EEC of 31 March 1992 on the Advertising of Medicinal Products for Human Use.Google Scholar
Coveney, Peter, and Highfield, Roger. 1995. Frontiers of Chaos: The Search for Order in a Chaotic World. New York: Fawcett Columbine.Google Scholar
Dolowitz, David, and Marsh, David. 2000. “Learning from abroad: the role of policy transfer in contemporary policy making.” Governance 13(1), 5–24.Google Scholar
Easterly, William. 2006. The White Man's Burden: Why the West's Efforts to Aid the Rest Have Done So Much Ill and So Little Good. New York: Penguin.Google Scholar
Fairclough, Norman. 2001. “The discourse of new labour: critical discourse analysis.” In Wetherall, Margaret, Taylor, Stephanie and Yates, Simeon (eds.), Discourse as Data: A Guide for Analysis. London: Sage Publications and the Open University, 229–266.Google Scholar
Fairclough, Norman. 2013. “Critical discourse analysis and critical policy studies.” Critical Policy Studies 7(2), 177–197.Google Scholar
Falk, Ian. 1994. “The making of policy: media discourse conversations.” Discourse 15(2), 1–12.Google Scholar
George, Susan. 1994. A Fate Worse Than Debt. London: Penguin.Google Scholar
Geyer, Robert. 2011. “The politics of EU health policy and the case of direct-to-consumer advertising for prescription drugs.” The British Journal of Politics and International Relations 13(4), 586–602.Google Scholar
Geyer, Robert. 2012. “Can complexity move UK policy beyond ‘evidence-based policy making’ and the ‘audit culture’? Applying a ‘complexity cascade’ to education and health policy.” Political Studies 60(1), 20–43.Google Scholar
Geyer, Robert, and Cairney, Paul (eds.). 2015. Handbook on Complexity and Public Policy. Cheltenham UK: Edward Elgar Publishing.Google Scholar
Geyer, Robert, and Rihani, Samir. 2010. Complexity and Public Policy: A New Approach to Twenty-First Century Politics, Policy and Society. Abingdon: Routledge.Google Scholar
Glinert, Lewis H. 2005. “TV commercials for prescription drugs: a discourse analytic perspective.” Research in Social and Administrative Pharmacy 1(2), 158–184.Google Scholar
Green, A. Richard, Haddad, Peter M. and Aronson, Jeffrey K.. 2018. “Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950–1980).” British Journal of Clinical Pharmacology 84, 1668–85.Google Scholar
Hamilton, Myra. 2014. “The ‘new social contract’ and the individualisation of risk in policy.” Journal of Risk Research 17(4), 453–467.Google Scholar
House of Commons. 2005. The Influence of the Pharmaceutical Industry: Fourth Report of Session 2004–05. London: Her Majesty's Stationery Office.Google Scholar
Jacobs, Keith. 2006. “Discourse analysis and its utility for urban policy research.” Urban Policy and Research 24(1), 39–52.Google Scholar
Jin, Zhe. 2016. “Treatment rate under 10%, imported antidepressants still prevail in China,” Daily Economist News, September 2016, http://www.nbd.com.cn/articles/2016-09-21/1040051.html. Accessed 12 Feb 2018.Google Scholar
Jones, Miren, Greenfield, Sheila M. and Bradley, Collin P.. 1999. “A survey of the advertising of nine new drugs in the general practice literature.” Journal of Clinical Pharmacy and Therapeutics 24(6), 451–460.Google Scholar
Kleinman, Arthur. 1982. “Neurasthenia and depression: a study of somatization and culture in China.” Culture, medicine and psychiatry 6(2), 117–190.Google Scholar
Kleinman, Arthur. 1992. “Culture and somatic experience: the social course of illness in neurasthenia and chronic fatigue syndrome.” Psychosomatic Medicine, 54, 546–560.Google Scholar
Larsen-Freeman, Diane. 1997. “Chaos/complexity science and second language acquisition.” Applied Linguistics 18(2), 141–165.Google Scholar
Larsen-Freeman, Diane, and Cameron, Lynne. 2008. Complex Systems and Applied Linguistics. Oxford: Oxford University Press.Google Scholar
Lee, Philip R., Lurie, Peter, Silverman, Milton M. and Lydecker, Mia. 1991. “Drug promotion and labeling in developing countries: an update.” Journal of Clinical Epidemiology 45, 49–55.Google Scholar
Lexchin, Joel. 2009. “Analysing pharmaceutical advertisements in medical journals.” Understanding and Responding to Pharmaceutical Promotion, 41–56.Google Scholar
Lin, Keh-Ming. 1980. “Traditional Chinese medical beliefs and their relevance for mental illness and psychiatry.” In Kleinman, Arthur and Lin, T. Y. (eds.), Normal and Abnormal Behavior in Chinese Culture. Dordrecht, Netherlands: D. Reidel, 95–111.Google Scholar
Lövdahl, Ulrica, Riska, Åsa and Riska, Elianne. 1999. “Gender display in Scandinavian and American advertising for antidepressants.” Scandinavian Journal of Public Health 27(4), 306–310.Google Scholar
Luke, Allan. 1997. “New narratives of human capital: recent redirections in Australian educational policy.” The Australian Educational Researcher 24(2), 1–21.Google Scholar
Ma, Feng, and Lou, Nan. 2013. “Regulation of drug promotion in China,” Update, FDLI, May/June 2013, https://www.cov.com/~/media/files/corporate/publications/2013/05/regulation_of_drug_promotion.pdf. Accessed 17 July 2016.Google Scholar
Mainzer, Klaus. 1997. “Symmetry and complexity: fundamental concepts of research in chemistry.” Hyle 3, 29–49.Google Scholar
Marston, Greg. 2000. “Metaphor, morality and myth: a critical discourse analysis of public housing policy in Queensland.” Critical Social Policy 20(3), 349–373.Google Scholar
Ng, Siu-man, Chan, Cecilia L.W., Ho, David Y.F., Wong, Yu-Yeuk and Ho, Rainbow T.H.. 2006. “Stagnation as a distinct clinical syndrome: comparing ‘yu’ (stagnation) in traditional Chinese medicine with depression.” British Journal of Social Work 36(3), 467–484.Google Scholar
PMCPA. 2018. The Prescription Medicines Code of Practice Authority, ABPI, http://www.pmcpa.org.uk/Pages/default.aspx. Accessed 19 July 2010.Google Scholar
Rihani, Samir. 2002. Complex Systems Theory and Development Practice. London: Zed Books.Google Scholar
Scott, Mike. 2008. WordSmith Tools Version 5.0. Liverpool: Lexical Analysis Software.Google Scholar
Sealey, Alison, and Carter, Bob. 2004. Applied Linguistics as Social Science. London: A&C Black.Google Scholar
Shi, Qiang, and Peixue, Ling. 2007. “The problems in the essential drugs list in China and proposed solutions.” Food and Drug 8(12A), 55–59.Google Scholar
Standing Committee of the NPC (National People's Congress) and SAIC (State Administration for Industry & Commerce). 2015. Advertisement Law of the People's Republic of China.Google Scholar
Stryer, Daniel, and Bero, Lisa A.. 1996. “Characteristics of materials distributed by drug companies.” Journal of General Internal Medicine 11(10), 575–583.Google Scholar
Wang, Fang. 2013. “A Social Constructionist Analysis of the Discourse of Mental Depression in British and Chinese news: A Corpus-based Study.” PhD diss., University of Birmingham.Google Scholar
WHO. 1988. Ethical Criteria for Medicinal Drug Promotion. Geneva: World Health Organization.Google Scholar
Zhan, Mei. 2011. “Human oriented? Angels and monsters in China's health-care reform.” East Asian Science, Technology and Society 5(3), 291–311.Google Scholar